Fast Facts: Biosimilars in Hematology and Oncology
Biologics and biosimilars - getting decisions right
Seiten
2020
S. Karger Publishers Ltd (Verlag)
978-1-912776-21-4 (ISBN)
S. Karger Publishers Ltd (Verlag)
978-1-912776-21-4 (ISBN)
Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: * Biologics and the need for biosimilars * Why do we need biosimilars? * How is the quality of biosimilar medicines assured? * Legal issues * Switching, interchangeability and extrapolation * Safety and pharmacovigilant * Global issues * Formulary considerations: pharmacy issues * Formulary considerations: supportive care biosimilars * Formulary considerations: therapeutic anti-cancer biosimilars * Communication and awareness
Erscheinungsdatum | 28.01.2020 |
---|---|
Zusatzinfo | 17 fig., 16 in color, 27 tab. |
Verlagsort | Basel |
Sprache | englisch |
Maße | 148 x 210 mm |
Gewicht | 220 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Schlagworte | Chemotherapy |
ISBN-10 | 1-912776-21-9 / 1912776219 |
ISBN-13 | 978-1-912776-21-4 / 9781912776214 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Handbuch für die Pflegepraxis
Buch | Softcover (2023)
Springer (Verlag)
CHF 55,95